Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin Dose

Mark J. Rieder, Alex P. Reiner, Brian F. Gage et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Simone Rost, Andreas Fregin, Vytautas Ivaškevičius et al. · Nature · 2004 · 1.1K citations

Medicine, Genetics, Molecular Genetics +12

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

Elizabeth Sconce, Tayyaba Khan, Hilary Wynne et al. · Blood · 2005 · 947 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Identification of the gene for vitamin K epoxide reductase

Tao Li, Chun-Yun Chang, Da-Yun Jin et al. · Nature · 2004 · 706 citations

Life Sciences, Biochemistry, Genetics +9

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin

Giovanna D’Andrea, Rosa D’Ambrosio, P Perna et al. · Blood · 2004 · 695 citations · Full text

Medicine, Genetics, Pharmacology +14